BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34318714)

  • 21. Lung epithelial cell-derived IL-25 negatively regulates LPS-induced exosome release from macrophages.
    Li ZG; Scott MJ; Brzóska T; Sundd P; Li YH; Billiar TR; Wilson MA; Wang P; Fan J
    Mil Med Res; 2018 Jul; 5(1):24. PubMed ID: 30056803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic interactions between PDE4B and GSK-3: DISC1 mutant mice.
    Lipina TV; Wang M; Liu F; Roder JC
    Neuropharmacology; 2012 Mar; 62(3):1252-62. PubMed ID: 21376063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NCS 613, a potent and specific PDE4 inhibitor, displays anti-inflammatory effects on human lung tissues.
    Yougbare I; Morin C; Senouvo FY; Sirois C; Albadine R; Lugnier C; Rousseau E
    Am J Physiol Lung Cell Mol Physiol; 2011 Oct; 301(4):L441-50. PubMed ID: 21784969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac Overexpression of PDE4B Blunts β-Adrenergic Response and Maladaptive Remodeling in Heart Failure.
    Karam S; Margaria JP; Bourcier A; Mika D; Varin A; Bedioune I; Lindner M; Bouadjel K; Dessillons M; Gaudin F; Lefebvre F; Mateo P; Lechène P; Gomez S; Domergue V; Robert P; Coquard C; Algalarrondo V; Samuel JL; Michel JB; Charpentier F; Ghigo A; Hirsch E; Fischmeister R; Leroy J; Vandecasteele G
    Circulation; 2020 Jul; 142(2):161-174. PubMed ID: 32264695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
    Seldon PM; Barnes PJ; Meja K; Giembycz MA
    Mol Pharmacol; 1995 Oct; 48(4):747-57. PubMed ID: 7476903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of rolipram on cyclic AMP levels in alveolar macrophages and lipopolysaccharide-induced inflammation in mouse lung.
    Gonçalves de Moraes VL; Singer M; Vargaftig BB; Chignard M
    Br J Pharmacol; 1998 Feb; 123(4):631-6. PubMed ID: 9517381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipsychotic profile of rolipram: efficacy in rats and reduced sensitivity in mice deficient in the phosphodiesterase-4B (PDE4B) enzyme.
    Siuciak JA; Chapin DS; McCarthy SA; Martin AN
    Psychopharmacology (Berl); 2007 Jun; 192(3):415-24. PubMed ID: 17333137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific Inhibition of Phosphodiesterase-4B Results in Anxiolysis and Facilitates Memory Acquisition.
    McGirr A; Lipina TV; Mun HS; Georgiou J; Al-Amri AH; Ng E; Zhai D; Elliott C; Cameron RT; Mullins JG; Liu F; Baillie GS; Clapcote SJ; Roder JC
    Neuropsychopharmacology; 2016 Mar; 41(4):1080-92. PubMed ID: 26272049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cigarette smoke up-regulates PDE3 and PDE4 to decrease cAMP in airway cells.
    Zuo H; Han B; Poppinga WJ; Ringnalda L; Kistemaker LEM; Halayko AJ; Gosens R; Nikolaev VO; Schmidt M
    Br J Pharmacol; 2018 Jul; 175(14):2988-3006. PubMed ID: 29722436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term or long-term treatments with a phosphodiesterase-4 (PDE4) inhibitor result in opposing agonist-induced Ca(2+) responses in endothelial cells.
    Campos-Toimil M; Keravis T; Orallo F; Takeda K; Lugnier C
    Br J Pharmacol; 2008 May; 154(1):82-92. PubMed ID: 18311187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Action of a Novel PDE4 inhibitor ZL-n-91 on lipopolysaccharide-induced acute lung injury.
    Tang HF; Lu JJ; Tang JF; Zheng X; Liang YQ; Wang XF; Wang YJ; Mao LG; Chen JQ
    Int Immunopharmacol; 2010 Apr; 10(4):406-11. PubMed ID: 20074667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophils counteract autophagy-mediated anti-inflammatory mechanisms in alveolar macrophage: role in posthemorrhagic shock acute lung inflammation.
    Wen Z; Fan L; Li Y; Zou Z; Scott MJ; Xiao G; Li S; Billiar TR; Wilson MA; Shi X; Fan J
    J Immunol; 2014 Nov; 193(9):4623-33. PubMed ID: 25267975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-124-3p targeting PDE4B attenuates LPS-induced ALI through the TLR4/NF-κB signaling pathway.
    Zhou Q; He DX; Deng YL; Wang CL; Zhang LL; Jiang FM; Irakoze L; Liang ZA
    Int Immunopharmacol; 2022 Apr; 105():108540. PubMed ID: 35063752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphodiesterase 4B gene transcription is activated by lipopolysaccharide and inhibited by interleukin-10 in human monocytes.
    Ma D; Wu P; Egan RW; Billah MM; Wang P
    Mol Pharmacol; 1999 Jan; 55(1):50-7. PubMed ID: 9882697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of phosphodiesterase 4B (PDE4B) activates protein kinase A and contributes to the progression of prostate cancer.
    Kashiwagi E; Shiota M; Yokomizo A; Itsumi M; Inokuchi J; Uchiumi T; Naito S
    Prostate; 2012 May; 72(7):741-51. PubMed ID: 22529021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphodiesterase 4B knockout prevents skeletal muscle atrophy in rats with burn injury.
    Balasubramaniam A; Sheriff S; Friend LA; James JH
    Am J Physiol Regul Integr Comp Physiol; 2018 Aug; 315(2):R429-R433. PubMed ID: 29693432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disease progression in MRL/lpr lupus-prone mice is reduced by NCS 613, a specific cyclic nucleotide phosphodiesterase type 4 (PDE4) inhibitor.
    Keravis T; Monneaux F; Yougbaré I; Gazi L; Bourguignon JJ; Muller S; Lugnier C
    PLoS One; 2012; 7(1):e28899. PubMed ID: 22247763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphodiesterase 4 mediates interleukin-8-induced heterologous desensitization of the β
    Rich TC; Leavesley SJ; Brandon AP; Evans CA; Raju SV; Wagener BM
    FASEB J; 2021 Oct; 35(10):e21946. PubMed ID: 34555226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rutaecarpine derivative Cpd-6c alleviates acute kidney injury by targeting PDE4B, a key enzyme mediating inflammation in cisplatin nephropathy.
    Liu XQ; Jin J; Li Z; Jiang L; Dong YH; Cai YT; Wu MF; Wang JN; Ma TT; Wen JG; Liu MM; Li J; Wu YG; Meng XM
    Biochem Pharmacol; 2020 Oct; 180():114132. PubMed ID: 32622666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Action of rolipram on specific PDE4 cAMP phosphodiesterase isoforms and on the phosphorylation of cAMP-response-element-binding protein (CREB) and p38 mitogen-activated protein (MAP) kinase in U937 monocytic cells.
    MacKenzie SJ; Houslay MD
    Biochem J; 2000 Apr; 347(Pt 2):571-8. PubMed ID: 10749688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.